Published in Br J Clin Pharmacol on February 01, 2004
Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol (2011) 0.83
Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals. Psychopharmacology (Berl) (2010) 0.77
Kinetics of pharmacologic response. Pharmacol Ther (1982) 2.21
Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med (1998) 1.91
Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations. Drug Metab Rev (1978) 1.54
Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther (1992) 1.41
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des (2002) 1.21
Midazolam infusions in critically ill patients. Eur J Anaesthesiol (1991) 1.08
The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther (1999) 1.08
Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther (1988) 1.03
Population pharmacodynamics of midazolam administered by target controlled infusion in SICU patients after CABG surgery. Anesthesiology (1998) 0.93
Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam. J Pharmacol Exp Ther (1999) 0.92
Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding. Eur J Pharmacol (1981) 0.92
Regional GABA/benzodiazepine receptor/chloride channel coupling after acute and chronic benzodiazepine treatment. Eur J Pharmacol (1989) 0.91
Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis. Br J Anaesth (2002) 0.90
Midazolam for sedation in the paediatric intensive care unit. Intensive Care Med (1991) 0.87
Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant. J Pharmacol Exp Ther (1993) 0.86
Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. J Pharmacol Exp Ther (1997) 0.85
Interchangeability and predictive performance of empirical tolerance models. Clin Pharmacokinet (1999) 0.84
Tolerance to alprazolam after intravenous bolus and continuous infusion: psychomotor and EEG effects. Clin Pharmacol Ther (1988) 0.84
A pharmacokinetic-pharmacodynamic model of tolerance to morphine analgesia during infusion in rats. J Pharmacokinet Biopharm (1995) 0.83
Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam. Clin Pharmacol Ther (1995) 0.82
A model for studying depth of anesthesia and acute tolerance to thiopental. Anesthesiology (1983) 0.81
Acute "tolerance" to the central respiratory effects of midazolam in the dog. Br J Anaesth (1982) 0.81
Acute tolerance and reversal of the motor control effects of midazolam. Pharmacol Biochem Behav (1998) 0.78
Pharmacokinetic-pharmacodynamic modelling of the EEG effects of Ro 48-6791, a new short-acting benzodiazepine, in young and elderly subjects. Br J Anaesth (1997) 0.78
Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med (2007) 4.99
Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain (2005) 2.42
Electroencephalogram monitoring during anesthesia with propofol and alfentanil: the impact of second order spectral analysis. Anesth Analg (2005) 1.41
Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation. Eur J Clin Pharmacol (2007) 1.41
Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology (2003) 1.37
Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science (2009) 1.34
Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg (2004) 1.34
Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version. Ger Med Sci (2010) 1.30
Retracted Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion. Anesthesiology (2004) 1.18
Secondary use of routinely collected patient data in a clinical trial: an evaluation of the effects on patient recruitment and data acquisition. Int J Med Inform (2012) 1.17
Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anesth Analg (2007) 1.17
Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment. Crit Care (2003) 1.11
The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain (2004) 1.02
Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology (2006) 1.00
Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain (2003) 0.99
Brucellosis of the lung: case report and review of the literature. Virchows Arch (2007) 0.98
Erroneously published fospropofol pharmacokinetic-pharmacodynamic data and retraction of the affected publications. Anesthesiology (2010) 0.98
Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine. Eur J Pain (2006) 0.96
Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain (2007) 0.92
Retracted Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers. Anesthesiology (2003) 0.92
Comparison of two electromyographical endotracheal tube systems for intraoperative recurrent laryngeal nerve monitoring: reliability and side effects. Langenbecks Arch Surg (2011) 0.89
Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model. J Pain (2005) 0.89
Intraoperative low-dose S-ketamine has no preventive effects on postoperative pain and morphine consumption after major urological surgery in children. Paediatr Anaesth (2005) 0.88
ECG artifacts during intraoperative high-field MRI scanning. J Neurosurg Anesthesiol (2004) 0.88
The in vivo neurochemistry of the brain during general anesthesia. J Neurochem (2011) 0.87
Retracted Sedation with GPI 15715, a water-soluble prodrug of propofol, using target-controlled infusion in volunteers. Anesth Analg (2005) 0.85
A priming technique accelerates onset of neuromuscular blockade at the laryngeal adductor muscles. Can J Anaesth (2005) 0.85
Evaluation of techniques for estimating the power spectral density of RR-intervals under paced respiration conditions. J Clin Monit Comput (2013) 0.84
[The DGAI CPR registry - the datasets "hospital care" and "long-term process"]. Anasthesiol Intensivmed Notfallmed Schmerzther (2008) 0.82
Pharmacodynamic modelling of rocuronium in adolescents with Duchenne muscular dystrophy. Eur J Anaesthesiol (2009) 0.81
The orofacial formalin test in mice revisited--effects of formalin concentration, age, morphine and analysis method. J Pain (2011) 0.80
Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol). Expert Opin Investig Drugs (2009) 0.79
Binding of propofol to human serum albumin. Arzneimittelforschung (2005) 0.79
Concentration-effect relations, prediction probabilities (Pk), and signal-to-noise ratios of different electroencephalographic parameters during administration of desflurane, isoflurane, and sevoflurane in rats. Anesthesiology (2008) 0.78
Anesthetic management of patients with ornithine transcarbamylase deficiency. Paediatr Anaesth (2006) 0.77
The discriminant power of simultaneous monitoring of spontaneous electroencephalogram and evoked potentials as a predictor of different clinical states of general anesthesia. Anesth Analg (2006) 0.77
Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy. Anesthesiology (2009) 0.77
Requested retraction of six studies on the PK/PD and tolerability of fospropofol. Anesth Analg (2010) 0.76
Determination of total and unbound sufentanil in human plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetic study. J Pharm Biomed Anal (2012) 0.76
The effects of paracetamol and parecoxib on kidney function in elderly patients undergoing orthopedic surgery. Anesth Analg (2006) 0.76
Milrinone combined with vasopressin improves cardiac index after cardiopulmonary resuscitation in a pig model of myocardial infarction. Anesthesiology (2007) 0.76
Does introduction of a Patient Data Management System (PDMS) improve the financial situation of an intensive care unit? BMC Med Inform Decis Mak (2013) 0.75
Requested retraction of six studies on the PK/PD and tolerability of fospropofol. Eur J Anaesthesiol (2010) 0.75
In Memoriam Prof. Dr Med. Thomas Pasch, FRCA. J Neurosurg Anesthesiol (2016) 0.75
High-frequency jet ventilation for complete target immobilization and reduction of planning target volume in stereotactic high single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Int J Radiat Oncol Biol Phys (2009) 0.75
Midazolam therapeutic drug monitoring in intensive care sedation: a 5-year survey. Ther Drug Monit (2004) 0.75
Patient-controlled Analgesia with Target-controlled Infusion of Hydromorphone in Postoperative Pain Therapy. Anesthesiology (2016) 0.75
A randomized open-label phase I pilot study of the safety and efficacy of total intravenous anesthesia with fospropofol for coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2013) 0.75
Psoas Versus Femoral Blocks: A Registry Analysis of Risks and Benefits. Reg Anesth Pain Med (2017) 0.75
Increase of propofol requirement after repeated administration for experimental anaesthesia. Eur J Anaesthesiol (2009) 0.75
Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy. Anesthesiology (2014) 0.75
Pediatric trauma anesthesia. Curr Opin Anaesthesiol (2002) 0.75
Analysis of total and unbound hydromorphone in human plasma by ultrafiltration and LC-MS/MS: application to clinical trial in patients undergoing open heart surgery. J Pharm Biomed Anal (2012) 0.75